Crossmark

Discovery and characterization of actionable tumor antigens

Crossref DOI link: https://doi.org/10.1186/s13073-019-0642-x

Published Online: 2019-04-30

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ehx, Grégory

Perreault, Claude https://orcid.org/0000-0001-9453-7383
Funding

Funding for this research was provided by:

N/A (N/A)
License Information

Text and Data Mining valid from 2019-04-30
More Information

Article History

First Online: 30 April 2019

Competing interests

: CP is a named inventor on a patent application entitled ‘Proteogenomic-based method for identifying tumor-specific antigens’ filed by Université de Montréal. GE has no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.